Monday, November 2, 2026
HomeETFsRPRX Crosses Above Average Analyst Target

RPRX Crosses Above Average Analyst Target

In recent trading, shares of Royalty Pharma plc (Symbol: RPRX) have crossed above the average analyst 12-month target price of $66.00, changing hands for $67.18/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v

www.nasdaq.com

RELATED ARTICLES

Access Denied

Access Denied

Most Popular

Recent Comments